Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 9Neuroendocrine Tumors 3Gastro-enteropancreatic neuroendocrine tumor 2Urogenital Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Diseases 1Prostate Cancer Metastatic 1Pheochromocytoma 1Paraganglioma 1Oligometastatic Prostate Cancer (OMPC) 1Neoplasm Metastasis 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-Resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Lung Neoplasms 1Digestive System Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma 1Breast Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1Advanced Gastroenteropancreatic Neuroendocrine Tumor 1

Interventions

Bevacizumab 5Cetuximab 3palbociclib 2encorafenib 2Leucovorin 2Irinotecan 2Fluorouracil 2tislelizumab 1ribociclib 1repotrectinib 1olaparib 1fludarabine 1durvalumab 1dostarlimab 1atezolizumab 1Tretinoin 1Stem Cell Transplantation 1Sirolimus 1Ramucirumab 1Radiotherapy 1Paclitaxel 1Oxaliplatin 1Oviposition 1Melphalan 1Lutetium-177 1Lutetium 1Levoleucovorin 1Injections 1Immunotherapy 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × Lutetium-177 × 1 year × Clear all
NCT07232407 2026-01-07

A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 1 Recruiting
22 enrolled
Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡